B

Bladder cancer: Adjuvant chemotherapy, systematic review and IPD meta-analysis

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data

Bladder cancer: Neoadjuvant chemotherapy, systematic review and IPD meta-analysis

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data

BLISTER

The bullous pemphigoid steroids and tetracyclines study

BLT

Big Lung Trial: A randomised trial to determine the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer

BO01

Two adjuvant chemotherapy regimens in the treatment of osteosarcoma

BO02

A randomised pilot study of two drug combinations in patients with osteosarcoma

BO03

A randomised trial of two-drug versus multi-drug chemotherapy in the treatment of operable osteosarcoma

BO04

A phase II study of cisplatin, ifosfamide and doxorubicin (PIA) chemotherapy in operable primary, axial skeletal and metastatic osteosarcoma

BO05

A phase II study of Adriamycin and cisplatin in spindle cell sarcoma of bone other than osteosarcoma

BO06

A randomised trial of chemotherapy with or without granulocyte colony stimulating factor (G-CSF) in operable osteosarcoma

BR01

Medical Research Council Study of Misonidazole in Conjunction with Radiotherapy for the Treatment of Malignant Gliomas (Astrocytomas) Grades III and IV

BR02

A Medical Research Council Study of Two Radiotherapy Dose Regimens for the Treatment of Adult Patients with Malignant Gliomas Grades III and IV

BR03

A study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytomas

BR04

Randomised trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: EORTC 22845 randomised trial

BR05

A randomised trial of adjuvant chemotherapy in high grade malignant glioma

BR12

Temozolomide versus PCV chemotherapy in the treatment of recurrent malignant glioma

BR13

Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade glioma after stratification for genetic 1p loss: a phase III study. Intergroup Study (EORTC 22033-26033)

BR14

Phase III trial on concurrent and adjuvant temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON Intergroup trial

BREATHER

Short-Cycle Therapy (SCT) (5 days on/2 days off) in young people with chronic HIV infection